EARLY DETECTION Stroke
The first time after a stroke determines the extent of cell damage in the brain. It is therefore particularly important to recognize a stroke and its symptoms early on.
Diagenics has patented antibodies to this enzyme and has already developed a new line of products for the early diagnosis of stroke: DIASTROKE®. The product was CE registered based on a study. Future studies will expand our expertise in stroke diagnosis.